Researchers have identified a new potential drug target for treating fragile x syndrome, with some studies suggesting that targeting specific genes or cells, such as astrocytes, may improve brain function. A novel gene therapy approach has also shown promise in restoring key features in a mouse model of the condition. The exact mechanism and target of the potential treatment are still being explored, with various strategies being investigated, including stimulating dna repair mechanisms and using the brain's own transport system.